Evidence map›Paper›PMID 39574011›Full record

ArticleBMC genomics2024

Single-cell sequencing of full-length transcripts and T-cell receptors with automated high-throughput Smart-seq3.

Hsiu-Chun Chuang, Ruidong Li, Huang Huang, Szu-Wen Liu, Christine Wan, Subhra Chaudhuri, Lili Yue, Terence Wong, Venina Dominical, Randy Yen and 7 more

Abstract read
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hsiu-Chun Chuang *Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Ruidong Li *Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Huang HuangGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Szu-Wen LiuGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Christine WanGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Subhra ChaudhuriGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Lili YueGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Terence WongGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Venina DominicalGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Randy YenGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Olivia NgoGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Nam BuiGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Hubert StopplerGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Tangsheng YiGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Silpa SuthramGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA.
Li LiGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA. li.li@gilead.com.
Kai-Hui SunGilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94403, USA. kaihui.sun1@gilead.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed an automated high-throughput Smart-seq3 (HT Smart-seq3) workflow that integrates best practices and an optimized protocol to enhance efficiency, scalability, and method reproducibility. This workflow consistently produces high-quality data with high cell capture efficiency and gene detection sensitivity. In a rigorous comparison with the 10X platform using human primary CD4 + T-cells, HT Smart-seq3 demonstrated higher cell capture efficiency, greater gene detection sensitivity, and lower dropout rates. Additionally, when sufficiently scaled, HT Smart-seq3 achieved a comparable resolution of cellular heterogeneity to 10X. Notably, through T-cell receptor (TCR) reconstruction, HT Smart-seq3 identified a greater number of productive alpha and beta chain pairs without the need for additional primer design to amplify full-length V(D)J segments, enabling more comprehensive TCR profiling across a broader range of species. Taken together, HT Smart-seq3 overcomes key technical challenges, offering distinct advantages that position it as a promising solution for the characterization of single-cell transcriptomes and immune repertoires, particularly well-suited for low-input, low-RNA content samples.

Indexed as

High-Throughput Nucleotide SequencingReceptors, Antigen, T-CellSingle-Cell AnalysisAnimalsCD4-Positive T-LymphocytesHumansReceptors, Antigen, T-Cell10XHigh-throughput Smart-seq3Single-cell RNA sequencingSingle-cell TCR sequencing

Identifiers

PMID39574011
PMCPMC11583680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.